Full-Time

Project Manager

Posted on 3/21/2025

Solventum

Solventum

5,001-10,000 employees

Compensation Overview

$160.3k - $195.9k/yr

+ Variable Incentive Pay

Senior, Expert

No H1B Sponsorship

San Antonio, TX, USA

Relocation Assistance: May be authorized; Must be legally authorized to work in country of employment without sponsorship for employment visa status (e.g., H1B status).

Category
Project Management
Business & Strategy
Requirements
  • Bachelor’s degree or higher in an Engineering or Science discipline from an accredited University
  • Minimum of 8 years of experience in the medtech/biotech industry in a private, public or governmental environment
  • Minimum of 3 years of project management and/or team leadership
  • Minimum of 5 years of experience with medical devices and FDA/ISO requirements
Responsibilities
  • Leads cross-functional teams to deliver project milestones on time, within budget, and in alignment with the strategic objectives of the program
  • Implements project management best practices to ensure the smooth execution and completion of projects
  • Determines project requirements and objectives by conducting detailed needs analyses, feasibility studies, and consultations with internal stakeholders and external partners
  • Supports project team members to ensure successful completion of deliverables including project reviews, design control deliverables, and business deliverables in a stage gate development process
  • Willingness to be on-call as needed to address critical project issues or emergencies
Desired Qualifications
  • Project Management Institute’s Project Management Professional (PMP) certification
  • Excellent communication skills (oral, written and presentation)
  • Ability to influence including clarifying risks and opportunities with stakeholders
  • Experience leading global cross-functional teams
  • Microsoft Office and Project proficient
  • Experience with New Product Introduction Process and Executing Gate Reviews, or other Phase-Gate Process

Company Size

5,001-10,000

Company Stage

N/A

Total Funding

N/A

Headquarters

N/A

Founded

N/A

Simplify Jobs

Simplify's Take

What believers are saying

  • Increased AI adoption enhances precision in Solventum's dental solutions.
  • Eco-friendly dental materials trend aligns with Solventum's potential product innovations.
  • Tele-dentistry demand offers opportunities for Solventum's digital solutions integration.

What critics are saying

  • Competition in 3D printing may reduce Solventum's market share.
  • Supply chain vulnerabilities could impact Solventum's 3D printing material availability.
  • Regulatory challenges may delay Solventum's new product commercialization.

What makes Solventum unique

  • Solventum's partnership with SprintRay focuses on same-day restorative dental solutions.
  • The Attest™ eBowie-Dick Test System revolutionizes sterilization assurance with electronic testing.
  • Solventum leverages innovative material science for durable dental restorations.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Remote Work Options

Paid Vacation

Paid Sick Leave

Paid Holidays

Hybrid Work Options

Relocation Assistance

Company News

PR Newswire
Apr 17th, 2025
Solventum To Report First Quarter Fiscal 2025 Earnings On May 8, 2025

ST. PAUL, Minn., April 17, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) will release its first quarter fiscal 2025 financial results on Thursday, May 8, 2025, after the U.S. financial markets close. After the release, Solventum management will host a webcast to discuss the results and its business. Other forward-looking and material information may also be discussed during the webcast

PR Newswire
Mar 25th, 2025
Solventum Partners With Sprintray To Disrupt The Digital Dentistry Market With High-Quality, Permanent Same-Day Restorations

In this first-of-its-kind partnership for its Dental Solutions business, Solventum, formerly 3M Health Care, is striving to focus on longevity and durability of permanent same-day restorative dental offerings, reaffirming its commitment to solving industry's toughest problemsPartnership aims to integrate innovative new material science and disruptive technology like chairside 3D printing to optimize workflows, enhance procedural efficiency and benefit both patients and practitioners ST. PAUL, Minn., March 25, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV), the leader in dental composites and restorative dentistry, today announced a strategic partnership with SprintRay, a leading provider of chairside 3D dental printing, to meet the needs of dentists with in-office chairside 3D printed crowns, inlays, onlays and more. This research and development (RD) and commercialization agreement is focused on developing and bringing to market high-quality, durable and permanent same-day restorations – with the quality patients and dentists expect from the current multi-visit laboratory fabricated procedures

PR Newswire
Mar 12th, 2025
Solventum Launches Attest™ Ebowie-Dick Test System Revolutionizing Sterilization Assurance

ST. PAUL, Minn., March 12, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV), formerly 3M Health Care, today announced the launch of the Attest™ eBowie-Dick Test System (eBowie-Dick System), an electronic test card and auto-reader for sterilization testing that eliminates the need for visual interpretation of results and manual documentation

INACTIVE